FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to a novel derivative of N-acylanthranilic acid, represented by the following general formula 1, or to its pharmaceutically acceptable salt, in which R1, R2, R3, X1, X2, X3, X4 and A are determined in the invention formula.
EFFECT: invention relates to an inhibitor of collagen production, a medication for treating diseases, associated with the excessive production of collagen, containing N-acylanthranilic acid derivative
Formula 1.
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | 2005 |
|
RU2394021C2 |
| CONDENSED AMINOHYDROTHIAZINE DERIVATIVE | 2009 |
|
RU2476431C2 |
| SYNTHETIC INTERMEDIATE COMPOUND 1-(2-DESOXY-2-FLUORO-4-THIO-β-D-ARABINOFURANOSYL)CYTOSINE, SYNTHETIC INTERMEDIATE THIONUCLEOSIDES COMPOUND AND METHOD FOR THEIR PRODUCTION | 2013 |
|
RU2633355C2 |
| ARYL-SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS | 2010 |
|
RU2575168C2 |
| MONOCYCLIC PYRIDINE DERIVATIVE | 2014 |
|
RU2645352C2 |
| 4-AMINOMETHYLBENZOIC ACID DERIVATIVES | 2014 |
|
RU2673245C2 |
| ACYLBENZENE DERIVATIVES | 2011 |
|
RU2585765C2 |
| AMINE COMPOUND AND ITS APPLICATION IN MEDICINAL PURPOSES | 2006 |
|
RU2433117C2 |
| C-PHENYL GLYCITOL COMPOUND FOR TREATING DIABETES | 2007 |
|
RU2437876C2 |
| PYRAZOLE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT | 2016 |
|
RU2687245C1 |
Authors
Dates
2014-10-10—Published
2010-01-29—Filed